A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Hematological Abnormalities in Patients With COVID-19: An Emerging Approach to Differentiate Between Severe COVID-19; Compared With NonSevere Forms of the Disease
Acta Medica Iranica
The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a pandemic threat from December 2019. Coronavirus can cause varying degrees of illness that range from mild to severe or fatal disease. The exact mechanism on hematopoiesis induced by this coronavirus is not yet well understood, but scientific evidence indicates that COVID-19 can cause hematological changes in infected patients. The present study summarized pieces ofdoi:10.18502/acta.v59i3.5781 fatcat:rgh66c74efgq5mku5d7ht7byey